Bank Of America Corp V Tv Therapeutics Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.66 - $40.8 $44 - $2,774	68 New	68 $0
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $11,348 - $22,252	-22,252 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.95 - $1.69 $21,098 - $37,533	22,209 Added 51648.84%	22,252 $22,000
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $2,561 - $3,716	-1,674 Reduced 97.5%	43 $0
Q2 2021 Sep 13, 2021	BUY	$2.27 - $3.44 $3,897 - $5,906	1,717 New	1,717 $4,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.33B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.